Evidence map›Paper›PMID 32411452›Full record

ArticleAIDS research and treatment2020

Prediction of CD4 T-Lymphocyte Count Using WHO Clinical Staging among ART-Naïve HIV-Infected Adolescents and Adults in Northern Ethiopia: A Retrospective Study.

Abraham Desta Aregay, Kibriti Mehari Kidane, Asfawosen Berhe Aregay, Kiros Ajemu Fenta, Ataklti Gebretsadik Woldegebriel, Hagos Godefay, Tewolde Wubayehu Woldearegay

Open access · goldAbstract read
In one paragraph

Article in AIDS research and treatment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Prevalence of uveitis in syphilis patients in Taiwan.Emerging microbes & infections · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Abraham Desta AregayTigray Health Research Institute, Mekelle, Tigray, Ethiopia.ORCID https://orcid.org/0000-0002-1505-7451
Kibriti Mehari KidaneTigray Health Research Institute, Mekelle, Tigray, Ethiopia.
Asfawosen Berhe AregayTigray Health Research Institute, Mekelle, Tigray, Ethiopia.ORCID https://orcid.org/0000-0003-1362-937X
Kiros Ajemu FentaTigray Health Research Institute, Mekelle, Tigray, Ethiopia.ORCID https://orcid.org/0000-0002-7608-0284
Ataklti Gebretsadik WoldegebrielTigray Health Research Institute, Mekelle, Tigray, Ethiopia.ORCID https://orcid.org/0000-0001-9957-3199
Hagos GodefayTigray Regional Health Bureau, Mekelle, Tigray, Ethiopia.
Tewolde Wubayehu WoldearegayTigray Health Research Institute, Mekelle, Tigray, Ethiopia.
Mekelle University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWHO clinical staging has long been used to assess the immunological status of HIV-infected patients at initiation of antiretroviral therapy and during treatment follow-up. In setups where CD4 count determination is not readily available, WHO clinical staging is a viable option. However, correlation between CD4 count and WHO clinical staging is not known in an Ethiopian setting, and hence, the main aim of this study was to assess predictability of CD4 T-lymphocyte count using WHO clinical staging among ART-naïve HIV-infected adolescents and adults in northern Ethiopia.

methodsA retrospective cross-sectional study was done in the Tigray Region, Ethiopia, from April 2015 to January 2019 from a secondary database of 19525 HIV-infected patients on antiretroviral treatment. Analysis was done using STATA-14.0 to estimate the frequencies, mean, and median of CD4 T-cell count in each WHO stages. Sensitivity, specificity, positive predictive value, negative predictive value, kappa test, and correlations were calculated to show the relationships between WHO stages and CD T-cell count.

resultsThe sensitivity of WHO clinical staging to predict CD4 T-cell counts of <200 cells/

conclusionsThe WHO clinical staging had high sensitivity but low specificity in predicting patients with CD4 count <200 cells/

Identifiers

PMID32411452
PMCPMC7210527
OpenAlexW3022375719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.